IMP-761

N/A

Report date: 2024/07/22 17:37:06

Base Information

Drug NameIMP-761
Drug Alias NameIMP761IMP 761IMP-761
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLymphocyte activation gene 3 protein stimulants
TargetsLymphocyte activation gene 3 protein
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmutep
China Registration ClassN/A

Develop Information

Active CompaniesImmutepImmutep LtdImmutep SAS
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A